{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:35:42Z","timestamp":1783485342084,"version":"3.55.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2161,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1111\/j.1365-2230.2008.03138.x","type":"journal-article","created":{"date-parts":[[2009,5,18]],"date-time":"2009-05-18T13:45:33Z","timestamp":1242654333000},"page":"776-780","source":"Crossref","is-referenced-by-count":67,"title":["Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study"],"prefix":"10.1093","volume":"34","author":[{"given":"B.","family":"Barikbin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Givrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Eskandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB1","first-page":"56.4","volume-title":"Rook\u2019s Textbook of Dermatology","author":"Goodfield","year":"2004"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB2","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/rheumatology\/kei093","article-title":"Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus","volume":"44","author":"Tlacuilo-Parra","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0190-9622(96)90690-8","article-title":"Guidelines of care for the use of topical glucocorticosteroids. American Academy of Dermatology","volume":"35","author":"Drake","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB4","first-page":"396","article-title":"Evaluation of the efficacy, safety and tolerability of tacrolimus ointment in Indian patients of moderate to severe atopic dermatitis: a multicentric, open label, phase III study","volume":"69","author":"Saple","year":"2003","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB5","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.clinthera.2006.12.014","article-title":"Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis","volume":"28","author":"Hebert","year":"2006","journal-title":"Clin Ther"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000107627","article-title":"Steroid-sparing effect of pimecrolimus cream 1% in children with severe atopic dermatitis","volume":"215","author":"Zuberbier","year":"2007","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2340\/00015555-0282","article-title":"Long-term treatment with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a two-year, multicentre, non-comparative study","volume":"87","author":"Reitamo","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB8","first-page":"50","article-title":"Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis","volume":"12","author":"Yoshimasu","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1365-2133.2002.488616.x","article-title":"The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus","volume":"147","author":"Walker","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB10","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/keh325","article-title":"Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative","volume":"43","author":"Lampropoulos","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB11","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archderm.141.9.1170","article-title":"0.1% Tacrolimus ointment in the treatment of discoid lupus erythematosus","volume":"141","author":"Heffernan","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1346-8138.2006.00203.x","article-title":"Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus","volume":"33","author":"Sugano","year":"2006","journal-title":"J Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-4632.2004.02539.x","article-title":"Efficacy of topical tacrolimus in the treatment of various cutaneous manifestations of lupus erythematosus","volume":"45","author":"von Pelchrzim","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.2006.07595.x","article-title":"Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study","volume":"156","author":"Tzung","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5070\/D31XH7Z688","article-title":"Treatment of cutaneous lupus with Elidel","volume":"8","author":"Zabawski","year":"2002","journal-title":"Dermatol Online J"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2004.01.044","article-title":"Pimecrolimus 1% cream for cutaneous lupus erythematosus","volume":"51","author":"Kreuter","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB18","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2133.1990.tb08290.x","article-title":"Recombinant interferon alpha 2a is effective in the treatment of discoid and subacute cutaneous lupus erythematosus","volume":"122","author":"Thivolet","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB20","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1067\/mjd.2001.109812","article-title":"Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children","volume":"44","author":"Kang","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB21","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/archderm.136.12.1497","article-title":"Detection of Type 1 cytokines in discoid lupus erythematosus","volume":"136","author":"Toro","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/path.1721","article-title":"Enhanced type I interferon signaling promotes Th1-biased inflammation in cutaneous lupus erythematosus","volume":"205","author":"Wenzel","year":"2005","journal-title":"J Pathol"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1468-3083.2003.00692.x","article-title":"Pimecrolimus. A review","volume":"17","author":"Gupta","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB24","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.0906-6705.2004.00269.x","article-title":"Pimecrolimus - an anti-inflammatory drug targeting the skin","volume":"13","author":"Grassberger","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1368-5031.2005.00587.x","article-title":"Pimecrolimus in dermatology. atopic dermatitis and beyond","volume":"59","author":"Gisondi","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijpharm.2003.07.013","article-title":"Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus","volume":"269","author":"Billich","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1111\/j.1365-2230.2008.03138.x-BIB27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1468-3083.2005.01315.x","article-title":"Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum","volume":"19","author":"Ring","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2008.03138.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2008.03138.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T05:38:38Z","timestamp":1684993118000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/34\/7\/776\/6625136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2008.03138.x","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}